SANJAY MATHEW to Neuroprotective Agents
This is a "connection" page, showing publications SANJAY MATHEW has written about Neuroprotective Agents.
Connection Strength
0.274
-
A randomized cross-over trial to define neurophysiological correlates of AV-101 N-methyl-D-aspartate receptor blockade in healthy veterans. Neuropsychopharmacology. 2021 03; 46(4):820-827.
Score: 0.154
-
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder. Neuropsychopharmacology. 2017 Dec; 42(13):2567-2574.
Score: 0.120